Shanghai Chest Hospital
Shanghai Chest Hospital
Shanghai, Shanghai Municipality, China11 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Camrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy in Resectable ESCC. | Resectable Esophageal Squamous Cell Carcinoma | Active, not recruiting | Phase 3 | 2026-09-17 | NCT05043688 | |
| A Phase 2 Study of Luvometinib Combined With Anlotinib in KRAS-mutated NSCLC | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Recruiting | Phase 2 | 2026-09-02 | NCT07562581 | |
| ART Trial: Transcatheter J-VALVE Versus Surgery for Aortic Regurgitation Therapy | aortic valve disorder, aortic valve insufficiency, cardiovascular disorder, heart disorder, heart valve disorder | Recruiting | Not applicable | 2026-08-12 | NCT07453407 | |
| China S3 PMS: SAPIEN 3 China Post Market Registry Study | Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorder | Active, not recruiting | Not stated | 2026-08-12 | NCT05168826 | |
| Surufatinib Combined With Chemo Versus Surufatinib in the Treatment of Pulmonary Neuroendocrine Tumors | Pulmonary Neuroendocrine Tumor | Recruiting | Phase 2 | 2026-01-22 | NCT07357623 | |
| Sleeve Lobectomy Following Neoadjuvant Therapy in NSCLC | Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not stated | 2025-12-31 | NCT07135856 | |
| Toripalimab Combined With Cryoablation for First-line Oligo-progression in Driver-negative Advanced NSCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2025-09-05 | NCT06127303 | |
| A Clinical Study of SYS6023 in Patients With Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | Phase 1 | 2025-08-08 | NCT07110883 | |
| EGM Guided PFA for PerAF | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder, persistent atrial fibrillation | Active, not recruiting | Not applicable | 2025-06-04 | NCT06729866 | |
| Precision Diagnosis and Prospective Cohort Study for Myasthenia Gravis: Multicenter Analysis in China | Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Recruiting | Not stated | 2025-05-28 | NCT04535843 | |
| First-line Treatment With Dacomitinib Plus Anlotinib for Patients With Advanced NSCLC With EGFR 21L858R Mutations | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 1 / Phase 2 | 2023-04-19 | NCT05271916 |